Chae Young Lee

Chae Young Lee

Auto-generated profile, based on publicly available information

Chae Young Lee

Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2021 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
APAe Kyung Park
Ae Kyung Park
IKIl-Hwan Kim
Il-Hwan Kim
JKJunyoung Kim
Junyoung Kim
JKJeong-Min Kim
Jeong-Min Kim
HKHeui Man Kim
Heui Man Kim
EKEun-Jin Kim
Eun-Jin Kim
Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

25 October 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
APAe Kyung Park
Ae Kyung Park
IKIl-Hwan Kim
Il-Hwan Kim
CLChae Young Lee
Chae Young Lee
JKJeong-Ah Kim
Jeong-Ah Kim
HLHyeokjin Lee
Hyeokjin Lee
EKEun-Jin Kim
Eun-Jin Kim
Ae Kyung Park, Ph.D., Il-Hwan Kim, Ph.D., Chae Young Lee, B.S., Jeong-Ah Kim, Ph.D., Hyeokjin Lee, M.S., Heui Man Kim, Ph.D., Nam-Joo Lee, M.S., SangHee Woo, M.S., Jaehee Lee, B.S., JeeEun Rhee, Ph.D., Cheon-Kwon Yoo, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2023;43:211-3. https://doi.org/10.3343/alm.2023.43.2.211

31 August 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
JKJeong-Min Kim
Jeong-Min Kim
DKDongju Kim
Dongju Kim
NLNam-Joo Lee
Nam-Joo Lee
SWSang Hee Woo
Sang Hee Woo
JLJaehee Lee
Jaehee Lee
EKEun-Jin Kim
Eun-Jin Kim
Objectives: Coronavirus disease 2019 (COVID-19) has been declared a global pandemic owing to the rapid spread of the causative agent, severe acute respiratory syndrome coronavirus 2. Its Delta and Omicron variants are more transmissible and pathogenic than other variants. Some debates have emerged on the mechanism of variants of concern. In the COVID-19 wave that began in December 2021, the Omicron variant, first reported in South Africa, became identifiable in most cases globally. The aim of this study was to provide data to inform effective responses to the transmission of the Omicron variant.Methods: The Delta variant and the spike protein D614G mutant were compared with the Omicron variant. Viral loads from 5 days after symptom onset were compared using epidemiological data collected at the time of diagnosis.Results: The Omicron variant exhibited a higher viral load than other variants, resulting in greater transmissibility within 5 days of symptom onset.Conclusion: Future research should focus on vaccine efficacy against the Omicron variant and compare trends in disease severity associated with its high viral load.

31 August 2025 in Viruses
Verified
Journal Article
Open access
PDF file
IKIl-Hwan Kim
Il-Hwan Kim
ELEun Ju Lee
Eun Ju Lee
JNJin Sun No
Jin Sun No
JNJi Yeong Noh
Ji Yeong Noh
CLChae Young Lee
Chae Young Lee
EKEun-Jin Kim
Eun-Jin Kim
Since the onset of the COVID-19 pandemic, the Republic of Korea has experienced continuous waves of SARS-CoV-2 variants. The current study aimed to analyze the long-term trends of variant prevalence and associated changes in immune responses within the country. Whole-genome sequencing was performed on confirmed patient samples collected from December 2020 to May 2025, and variant distribution, genetic diversity, and neutralization were compared. As a result of analyzing a total of 157,962 gene sequences, various Omicron sub-lineages, including BA.1, BA.2, BA.5, followed by JN.1, KP.3, and NB.1.8.1, were seen to circulate sequentially over time. The nucleotide diversity of the SARS-CoV-2 genome gradually increased after the JN.1 outbreak. Of the tested variants, hamster antiserum neutralization analysis indicated that Omicron NB.1.8.1, which began to circulate in 2025, exhibited the lowest neutralization activity, with an approximately 6.6-fold decrease compared to JN.1. This suggests a potential expansion in the dominance of new variants with enhanced immune evasion. As the transmission of SARS-CoV-2 continues, new variants with novel characteristics may emerge; therefore, continuous national genomic surveillance and immunological characterization are considered crucial for early detection of emerging variants and for guiding effective public health responses.

28 November 2023 in Virology
Verified
Journal Article
Closed access
DLDong-Wook Lee
Dong-Wook Lee
JKJeong-Min Kim
Jeong-Min Kim
DKDa-Won Kim
Da-Won Kim
JKJi-Yun Kim
Ji-Yun Kim
CLChae Young Lee
Chae Young Lee
JKJunghoon Kwon
Junghoon Kwon

13 December 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
ELEun Ju Lee
Eun Ju Lee
HLHyeokjin Lee
Hyeokjin Lee
SOSang Won O
Sang Won O
JRJee Eun Rhee
Jee Eun Rhee
JKJeong-Min Kim
Jeong-Min Kim
EKEun-Jin Kim
Eun-Jin Kim
Eun Ju Lee, M.S., Hyeokjin Lee, M.S., Sang Won O, M.S., Jee Eun Rhee, Ph.D., Jeong-Min Kim, Ph.D., Dong Ju Kim, M.S., Il-Hwan Kim, Ph.D., Jin Sun No, Ph.D., Ae Kyung Park, Ph.D., Jeong-Ah Kim, Ph.D., Chae Young Lee, B.S., Young-Ki Choi, Ph.D., and Eun-Jin Kim, Ph.D.. Ann Lab Med 2024;44:289-93. https://doi.org/10.3343/alm.2023.0256